Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review

Abstract Background Lack of agreed terminology and definitions in healthcare compromises communication, patient safety, optimal management of adverse events, and research progress. The purpose of this scoping review was to understand the terminologies used to describe central venous access devices (...

Full description

Bibliographic Details
Main Authors: Kerrie Curtis, Karla Gough, Meinir Krishnasamy, Elena Tarasenko, Geoff Hill, Samantha Keogh
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-12099-8
_version_ 1797199338905010176
author Kerrie Curtis
Karla Gough
Meinir Krishnasamy
Elena Tarasenko
Geoff Hill
Samantha Keogh
author_facet Kerrie Curtis
Karla Gough
Meinir Krishnasamy
Elena Tarasenko
Geoff Hill
Samantha Keogh
author_sort Kerrie Curtis
collection DOAJ
description Abstract Background Lack of agreed terminology and definitions in healthcare compromises communication, patient safety, optimal management of adverse events, and research progress. The purpose of this scoping review was to understand the terminologies used to describe central venous access devices (CVADs), associated complications and reasons for premature removal in people undergoing cancer treatment. It also sought to identify the definitional sources for complications and premature removal reasons. The objective was to map language and descriptions used and to explore opportunities for standardisation. Methods A systematic search of MedLine, PubMed, Cochrane, CINAHL Complete and Embase databases was performed. Eligibility criteria included, but were not limited to, adult patients with cancer, and studies published between 2017 and 2022. Articles were screened and data extracted in Covidence. Data charting included study characteristics and detailed information on CVADs including terminologies and definitional sources for complications and premature removal reasons. Descriptive statistics, tables and bar graphs were used to summarise charted data. Results From a total of 2363 potentially eligible studies, 292 were included in the review. Most were observational studies (n = 174/60%). A total of 213 unique descriptors were used to refer to CVADs, with all reasons for premature CVAD removal defined in 84 (44%) of the 193 studies only, and complications defined in 56 (57%) of the 292 studies. Where available, definitions were author-derived and/or from national resources and/or other published studies. Conclusion Substantial variation in CVAD terminology and a lack of standard definitions for associated complications and premature removal reasons was identified. This scoping review demonstrates the need to standardise CVAD nomenclature to enhance communication between healthcare professionals as patients undergoing cancer treatment transition between acute and long-term care, to enhance patient safety and rigor of research protocols, and improve the capacity for data sharing.
first_indexed 2024-04-24T07:14:10Z
format Article
id doaj.art-796ee4f9ef29433fa7c4c44679e35fb0
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-24T07:14:10Z
publishDate 2024-04-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-796ee4f9ef29433fa7c4c44679e35fb02024-04-21T11:21:54ZengBMCBMC Cancer1471-24072024-04-0124111710.1186/s12885-024-12099-8Central venous access device terminologies, complications, and reason for removal in oncology: a scoping reviewKerrie Curtis0Karla Gough1Meinir Krishnasamy2Elena Tarasenko3Geoff Hill4Samantha Keogh5Department of Nursing, University of MelbourneDepartment of Nursing, University of MelbourneDepartment of Nursing, University of MelbourneAustin HealthRoyal Melbourne HospitalCentre for Healthcare Transformation, Queensland University of TechnologyAbstract Background Lack of agreed terminology and definitions in healthcare compromises communication, patient safety, optimal management of adverse events, and research progress. The purpose of this scoping review was to understand the terminologies used to describe central venous access devices (CVADs), associated complications and reasons for premature removal in people undergoing cancer treatment. It also sought to identify the definitional sources for complications and premature removal reasons. The objective was to map language and descriptions used and to explore opportunities for standardisation. Methods A systematic search of MedLine, PubMed, Cochrane, CINAHL Complete and Embase databases was performed. Eligibility criteria included, but were not limited to, adult patients with cancer, and studies published between 2017 and 2022. Articles were screened and data extracted in Covidence. Data charting included study characteristics and detailed information on CVADs including terminologies and definitional sources for complications and premature removal reasons. Descriptive statistics, tables and bar graphs were used to summarise charted data. Results From a total of 2363 potentially eligible studies, 292 were included in the review. Most were observational studies (n = 174/60%). A total of 213 unique descriptors were used to refer to CVADs, with all reasons for premature CVAD removal defined in 84 (44%) of the 193 studies only, and complications defined in 56 (57%) of the 292 studies. Where available, definitions were author-derived and/or from national resources and/or other published studies. Conclusion Substantial variation in CVAD terminology and a lack of standard definitions for associated complications and premature removal reasons was identified. This scoping review demonstrates the need to standardise CVAD nomenclature to enhance communication between healthcare professionals as patients undergoing cancer treatment transition between acute and long-term care, to enhance patient safety and rigor of research protocols, and improve the capacity for data sharing.https://doi.org/10.1186/s12885-024-12099-8Central venous cathetersCatheters indwellingCentral venous access deviceDevice removalComplicationPremature removal
spellingShingle Kerrie Curtis
Karla Gough
Meinir Krishnasamy
Elena Tarasenko
Geoff Hill
Samantha Keogh
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
BMC Cancer
Central venous catheters
Catheters indwelling
Central venous access device
Device removal
Complication
Premature removal
title Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
title_full Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
title_fullStr Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
title_full_unstemmed Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
title_short Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
title_sort central venous access device terminologies complications and reason for removal in oncology a scoping review
topic Central venous catheters
Catheters indwelling
Central venous access device
Device removal
Complication
Premature removal
url https://doi.org/10.1186/s12885-024-12099-8
work_keys_str_mv AT kerriecurtis centralvenousaccessdeviceterminologiescomplicationsandreasonforremovalinoncologyascopingreview
AT karlagough centralvenousaccessdeviceterminologiescomplicationsandreasonforremovalinoncologyascopingreview
AT meinirkrishnasamy centralvenousaccessdeviceterminologiescomplicationsandreasonforremovalinoncologyascopingreview
AT elenatarasenko centralvenousaccessdeviceterminologiescomplicationsandreasonforremovalinoncologyascopingreview
AT geoffhill centralvenousaccessdeviceterminologiescomplicationsandreasonforremovalinoncologyascopingreview
AT samanthakeogh centralvenousaccessdeviceterminologiescomplicationsandreasonforremovalinoncologyascopingreview